Cumberland Pharmaceuticals Inc.: net_income
| Value | {"amount": -6963068, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:03.146245+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e79b2149-fab8-40ee-9b1b-d864ec025808
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-19-002785Retrieved: 2026-08-19T10:49:03.146245+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/net-income/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e79b2149-fab8-40ee-9b1b-d864ec025808
History
- no predecessors — first report